Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.27 USD | +1.99% |
|
+14.88% | -1.15% |
Jun. 17 | Zymeworks Says FDA Clears Investigational New Drug Application for Cancer Therapy | MT |
Jun. 17 | Zymeworks Gets FDA OK to Study ZW171 for Mesothelin-Expressing Cancers | DJ |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.15% | 732M | |
+20.63% | 127B | |
+25.27% | 27.67B | |
-20.17% | 20.33B | |
-16.61% | 16.79B | |
-18.07% | 15.63B | |
-47.70% | 14.65B | |
+11.92% | 14.84B | |
+58.32% | 14.43B | |
+149.98% | 12.49B |
- Stock Market
- Equities
- ZYME Stock
- News Zymeworks Inc.
- Transcript : Zymeworks Inc. Presents at Wolfe Research 2nd Annual Healthcare Conference, Nov-19-2020 02